Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and early trials suggest very strong ...
Establishments using a U.S.-origin claim on FSIS-regulated products will need to provide access to documentation ...
Medically reviewed by Kristie Reed, PharmD Magnesium and potassium are important for muscle contraction, heart rhythms, and ...
Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
Establishments using US-origin claims will need to demonstrate the product meets regulatory requirements, effective Jan. 1.
More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...
FDA's new guidance clarifies promotional practices for biosimilars, ensuring accurate marketing and preventing misleading ...
In 2022, the year ByHeart started making formula, the company recalled five batches of infant formula after a sample at a ...
The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.
FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...
Johnson explained in a November webinar hosted by AIB International that food and safety policies are more frequently being ...
Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback